Skip to content
Clinical Trials – home
PortugalBack to Portugal

Clinical trials in Ponte De Lima – page 12

312 clinical trials in Ponte De Lima, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.

PortugalOur site in PortugalEnsaios-Clinicos.pt(opens in a new tab)
Ponte De Lima at a glance
312
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

312 trials in Ponte De Lima

Open in trial search

Myasthenia gravis

Not yet recruiting

Efficacy and Safety of DNTH103 in Adults with Generalized Myasthenia Gravis: A Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:DNTH103
  • Sponsor:Dianthus Therapeutics Inc.

Randomized Phase 3 Study of Deupirfenidone (LYT‑100) versus Pirfenidone in Adults with Idiopathic Pulmonary Fibrosis

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Deupirfenidone
  • Sponsor:Celea Therapeutics Inc.

Efficacy and Safety of Pegcetacoplan in Adults and Adolescents with Focal Segmental Glomerulosclerosis: Phase 2/3 Open‑Label and Randomized Placebo‑Controlled Study

Registered drug
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pegcetacoplan
  • Sponsor:Apellis Pharmaceuticals Inc.

Urinary tract infection

Not yet recruiting

MV140 for Women with Recurrent Uncomplicated Urinary Tract Infections

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Ascorbic Acid
  • Sponsor:Inmunotek S.L.

Type 2 diabetes mellitus

Not yet recruiting

A study to evaluate the effectiveness of NNC0662-0419 and semaglutide in people with type 2 diabetes

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · Healthy volunteers
  • Substances:NNC0662-0419
  • Sponsor:Novo Nordisk A/S

Pneumonia bacterial

Not yet recruiting

Safety and tolerability study of bacteriophage cocktail TP-122A given by inhalation in adults with ventilator-associated pneumonia

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Demerecviridae bacteriophage against klebesiella pneumoniae (113.073 BP)
  • Sponsor:Technophage Investigacao E Desenvolvimento Em Biotecnologia S.A.

Study on the Safety and Effectiveness of Oxitriptan and Tamsulosin Hydrochloride for Patients with Benign Prostatic Hyperplasia

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Oxitriptan
  • Sponsor:CCAB Centro Clinico Academico Braga Associacao

Colitis ulcerative

Not recruiting

Evaluation of Long-Term Efficacy and Safety of Obefazimod as Maintenance Therapy in Patients with Moderately to Severely Active Ulcerative Colitis

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type

Registered drug
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Type 2 diabetes mellitus+2

Not recruiting

Zenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Phase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus

Registered drug
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Emtricitabine
  • Sponsor:Novartis Pharma AG

Arteriosclerosis

Not recruiting

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Olpasiran
  • Sponsor:Amgen Inc.

Other cities in Portugal

The busiest research cities in the country

All 48 cities in Portugal

Clinical research in Ponte De Lima

What the registry says about research in the country

01 Rheumatoid and Psoriatic Arthritis Studies

Innovative research focusing on rheumatoid arthritis and psoriatic arthritis treatments, evaluating new therapeutic approaches including zasocitinib and sonelokimab for patients who haven't received biological medicines.

  • Novel biologic therapies
  • Treatment comparisons
  • Disease activity reduction

Multiple trials are examining both established and experimental treatments for improved patient outcomes.

02 Autoimmune Conditions

Comprehensive studies targeting various autoimmune conditions, including Sjögren's Syndrome and Systemic Lupus Erythematosus, with a focus on evaluating new therapeutic options like dazodalibep and upadacitinib.

  • Systemic disease management
  • Long-term safety evaluation
  • Symptom control

Research aims to address both systemic manifestations and quality of life improvements.

03 Inflammatory Conditions

Studies investigating treatments for Crohn's Disease and Ulcerative Colitis, with particular attention to maintenance therapy and long-term disease management strategies.

  • Digestive system disorders
  • Extended treatment efficacy
  • Novel therapeutic approaches

Focus on developing sustainable treatment options for chronic inflammatory conditions.

04 Specialized Therapeutic Areas

Advanced research into conditions like Giant Cell Arteritis and Systemic Sclerosis, evaluating targeted treatments including secukinumab and HZN-825.

  • Rare disease interventions
  • Tissue-specific treatments
  • Progressive disease management

Emphasis on developing specialized treatments for complex medical conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.